Remove Antibody Remove Business Development Remove Pharma Production
article thumbnail

Innate Pharma and Takeda sign licence deal to develop ADCs for coeliac disease

Pharmaceutical Technology

Innate Pharma has signed an exclusive licence agreement with Takeda to enable research and development of antibody drug conjugates (ADCs) against an undisclosed target, primarily focusing on coeliac disease. Innate will receive an upfront payment of $5m as part of the agreement.

article thumbnail

Leading freeze-drying systems suppliers for the pharmaceutical industry

Pharmaceutical Technology

Also known as lyophilisation, the technique stabilises and preserves sensitive products such as biologics, and diagnostic kits, in a permanently storable state. The companies offer systems for more dynamic freeze-drying of products with more precision in control.